BACKGROUND: The human immunodeficiency virus (HIV)-infected population in the United States is increasing by about 30 000 annually (new infections minus deaths). With improvements in diagnosis and engagement in care, additional qualified HIV care providers may be needed. METHODS: We surveyed a probability sample of 2023 US HIV care providers in 2013-2014, including those at Ryan White HIV/AIDS Program (RWHAP)-funded facilities and in private practices. We estimated future patient care capacity by comparing counts of providers entering and planning to leave practice within 5 years, and the number of patients under their care. RESULTS: Of surveyed providers, 1234 responded (adjusted response rate, 64%): 63% were white, 11% black, 11% Hispanic, and 16% other race/ethnicity; 37% were satisfied/very satisfied with salary/reimbursement, and 33% were satisfied/very satisfied with administrative time. Compared with providers in private practice, more providers at RWHAP-funded facilities were HIV specialists (71% vs 43%; P < .0001) and planned to leave HIV practice within 5 years (11% vs 4%; P = .0004). An estimated 190 more full-time equivalent providers (defined as 40 HIV clinical care hours per week) entered practice in the past 5 years than are expected to leave in the next 5 years. If these rates continue, by 2019 patient care capacity will increase by 65 000, compared with an increased requirement of at least 100 000. CONCLUSIONS: Projected workforce growth by 2019 will not accommodate the increased number of HIV-infected persons requiring care. RWHAP-funded facilities may face attrition of highly qualified providers. Dissatisfaction with salary/reimbursement and administrative burden is substantial, and black and Hispanic providers are underrepresented relative to HIV patients. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: The humanimmunodeficiency virus (HIV)-infected population in the United States is increasing by about 30 000 annually (new infections minus deaths). With improvements in diagnosis and engagement in care, additional qualified HIV care providers may be needed. METHODS: We surveyed a probability sample of 2023 US HIV care providers in 2013-2014, including those at Ryan White HIV/AIDS Program (RWHAP)-funded facilities and in private practices. We estimated future patient care capacity by comparing counts of providers entering and planning to leave practice within 5 years, and the number of patients under their care. RESULTS: Of surveyed providers, 1234 responded (adjusted response rate, 64%): 63% were white, 11% black, 11% Hispanic, and 16% other race/ethnicity; 37% were satisfied/very satisfied with salary/reimbursement, and 33% were satisfied/very satisfied with administrative time. Compared with providers in private practice, more providers at RWHAP-funded facilities were HIV specialists (71% vs 43%; P < .0001) and planned to leave HIV practice within 5 years (11% vs 4%; P = .0004). An estimated 190 more full-time equivalent providers (defined as 40 HIV clinical care hours per week) entered practice in the past 5 years than are expected to leave in the next 5 years. If these rates continue, by 2019 patient care capacity will increase by 65 000, compared with an increased requirement of at least 100 000. CONCLUSIONS: Projected workforce growth by 2019 will not accommodate the increased number of HIV-infectedpersons requiring care. RWHAP-funded facilities may face attrition of highly qualified providers. Dissatisfaction with salary/reimbursement and administrative burden is substantial, and black and Hispanic providers are underrepresented relative to HIVpatients. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
HIV provider; capacity; workforce survey
Authors: Joseph R Betancourt; Alexander R Green; J Emilio Carrillo; Owusu Ananeh-Firempong Journal: Public Health Rep Date: 2003 Jul-Aug Impact factor: 2.792
Authors: Michael Ohl; Janet Tate; Mona Duggal; Melissa Skanderson; Matthew Scotch; Peter Kaboli; Mary Vaughan-Sarrazin; Amy Justice Journal: Med Care Date: 2010-12 Impact factor: 2.983
Authors: William D King; Mitchell D Wong; Martin F Shapiro; Bruce E Landon; William E Cunningham Journal: J Gen Intern Med Date: 2004-11 Impact factor: 5.128
Authors: S E Cohn; M L Berk; S H Berry; N Duan; M R Frankel; J D Klein; M M McKinney; A Rastegar; S Smith; M F Shapiro; S A Bozzette Journal: J Acquir Immune Defic Syndr Date: 2001-12-01 Impact factor: 3.731
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Martin R Frankel; Ad McNaghten; Martin F Shapiro; Patrick S Sullivan; Sandra H Berry; Christopher H Johnson; Elaine W Flagg; Sally Morton; Samuel A Bozzette Journal: Open AIDS J Date: 2012-09-07
Authors: A D McNaghten; Mitchell I Wolfe; Ida Onorato; Allyn K Nakashima; Ronald O Valdiserri; Eve Mokotoff; Raul A Romaguera; Alice Kroliczak; Robert S Janssen; Patrick S Sullivan Journal: PLoS One Date: 2007-06-20 Impact factor: 3.240
Authors: Brian R Wood; Christopher Bell; Jason Carr; Richard Aleshire; Christopher B Behrens; Shelia B Dunaway; Javeed A Shah; Ruanne V Barnabas; Margaret L Green; Christian B Ramers; Pegi L Fina; H Nina Kim; Robert D Harrington Journal: AIDS Care Date: 2018-05-31
Authors: John Weiser; Guangnan Chen; Linda Beer; Daria Boccher-Lattimore; Wendy Armstrong; Ann Kurth; R Luke Shouse Journal: Health Serv Res Date: 2019-07-01 Impact factor: 3.402
Authors: Constance A Benson; Judith S Currier; Carlos Del Rio; Joel E Gallant; Roy M Gulick; Jeanne M Marrazzo; Douglas D Richman; Michael S Saag; Robert T Schooley; Paul A Volberding Journal: Top Antivir Med Date: 2017 Dec/Jan
Authors: Rupa R Patel; Philip A Chan; Laura C Harrison; Kenneth H Mayer; Amy Nunn; Leandro A Mena; William G Powderly Journal: LGBT Health Date: 2018-04-24 Impact factor: 4.151
Authors: Nwora Lance Okeke; Allison R Webel; Hayden B Bosworth; Angela Aifah; Gerald S Bloomfield; Emily W Choi; Sarah Gonzales; Sarah Hale; Corrilynn O Hileman; Virginie Lopez-Kidwell; Charles Muiruri; Megan Oakes; Julie Schexnayder; Valerie Smith; Rajesh Vedanthan; Chris T Longenecker Journal: Am Heart J Date: 2019-07-18 Impact factor: 4.749
Authors: Kathy K Byrd; Felicia Hardnett; Patrick G Clay; Ambrose Delpino; Ron Hazen; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Paul J Weidle Journal: AIDS Patient Care STDS Date: 2019-01-16 Impact factor: 5.078
Authors: D S Graciaa; M Machaidze; M Kipiani; M Buziashvili; K Barbakadze; Z Avaliani; R R Kempker Journal: Int J Tuberc Lung Dis Date: 2018-11-01 Impact factor: 2.373
Authors: Joyonna Carrie Gamble-George; Christopher T Longenecker; Allison R Webel; David H Au; Arleen F Brown; Hayden Bosworth; Kristina Crothers; William E Cunningham; Kevin A Fiscella; Alison B Hamilton; Christian D Helfrich; Joseph A Ladapo; Amneris Luque; Jonathan N Tobin; Gail E Wyatt Journal: Prog Cardiovasc Dis Date: 2020-03-19 Impact factor: 8.194